Patents Assigned to Inheris Pharmaceuticals, Inc.
  • Patent number: 10512644
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: December 24, 2019
    Assignee: Inheris Pharmaceuticals, Inc.
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley